Recombinant Human APOC2 Protein, C-His

Introduction

Recombinant Human APOC2 Protein, also known as Apolipoprotein C-II, is a crucial protein involved in lipid metabolism and transport. It is a small 79-amino acid protein that plays a significant role in the breakdown of triglycerides in the blood. In this article, we will discuss the structure, activity, and application of Recombinant Human APOC2 Protein.

Structure of Recombinant Human APOC2 Protein

The gene for APOC2 is located on chromosome 19 and is composed of three exons. The mature protein has a molecular weight of approximately 8.8 kDa and is composed of 79 amino acids. It has a unique structure with four helices and a beta-sheet, which is stabilized by four disulfide bonds. The N-terminal helix contains a highly conserved sequence, which is responsible for binding to lipoproteins.

Activity of Recombinant Human APOC2 Protein

The primary function of APOC2 is to activate lipoprotein lipase (LPL), an enzyme that breaks down triglycerides into free fatty acids and glycerol. APOC2 binds to LPL and helps it to attach to the surface of chylomicrons and very low-density lipoproteins (VLDL). This interaction results in the hydrolysis of triglycerides and the release of fatty acids, which can be used as an energy source by various tissues. In addition to its role in lipid metabolism, APOC2 also has anti-inflammatory properties and regulates the activity of other enzymes involved in cholesterol metabolism.

Application of Recombinant Human APOC2 Protein

Recombinant Human APOC2 Protein has various applications in the field of medicine and biotechnology. One of the primary uses of this protein is in the treatment of hypertriglyceridemia, a condition characterized by high levels of triglycerides in the blood. APOC2 deficiency is a rare genetic disorder that leads to severe hypertriglyceridemia and can be treated by administering recombinant APOC2 protein. It has also been used in clinical trials to treat other lipid disorders such as familial chylomicronemia syndrome and familial hypercholesterolemia.

Recombinant Protein Production

Recombinant Human APOC2 Protein can be produced using various techniques, including recombinant DNA technology. The gene encoding APOC2 is cloned into a suitable expression vector and then introduced into host cells, such as bacteria or yeast, for production. The recombinant protein is then purified and characterized to ensure its quality and activity.

Antigen for Research

Recombinant Human APOC2 Protein is also used as an antigen in research studies to develop diagnostic tools and therapeutic agents for various lipid disorders. It can be used to generate specific antibodies that can be used to detect and quantify APOC2 levels in biological samples. These antibodies can also be used in immunoassays, such as ELISA, to study the role of APOC2 in different diseases.

Future Possibilities

Recombinant Human APOC2 Protein has shown promising results in treating hypertriglyceridemia and other lipid disorders. Further research is being conducted to explore its potential in other areas, such as cardiovascular disease, obesity, and diabetes. As our understanding of APOC2 and its functions continues to grow, there is a possibility of developing new therapies and treatments for